Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Nrx clonazepam tablet uses?Acarbose biosynthetic pathway patent?Generic name of ambien?Leucovorin generic name?Spravato sales revenue janssen 2025 or 2026?
See the DrugPatentWatch profile for Vyvanse
What conditions are Vyvanse off-label uses approved for? Vyvanse (lisdexamfetamine) is a prescription medication primarily used to treat attention deficit hyperactivity disorder (ADHD). However, due to its stimulant properties, it has been prescribed off-label for various conditions [1]. Some approved off-label uses of Vyvanse include: * Narcolepsy: Vyvanse has been used to help manage excessive daytime sleepiness in patients with narcolepsy [1]. * Binge eating disorder: Studies have shown that Vyvanse can be effective in reducing symptoms of binge eating disorder in adults [2]. * Chronic fatigue syndrome: Some doctors have prescribed Vyvanse off-label for patients with chronic fatigue syndrome, although its effectiveness for this condition is not well established [3]. * Sleep apnea: Vyvanse has been used off-label to help manage excessive daytime sleepiness in patients with sleep apnea [4]. What happens if I use Vyvanse off-label without medical supervision? Using Vyvanse off-label without proper medical supervision can lead to various complications, including: * Overdose: Taking too much Vyvanse can lead to overdose symptoms such as hallucinations, confusion, agitation, and even cardiac arrest [5]. * Dependence and addiction: Vyvanse contains amphetamines, which are highly addictive. Using the medication without proper medical supervision can lead to dependence and addiction [5]. * Interactions with other medications: Vyvanse can interact with other medications, such as blood thinners, and decrease their effectiveness or increase the risk of side effects [6]. When does exclusivity expire? The patent for Vyvanse expires in 2030 [7]. Sources: [1] https://www.drugs.com/vyvanse.html [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745141/ [3] https://www.mayoclinic.org/diseases-conditions/chronic-fatigue-syndrome/expert-answers/vyvanse/faq-20058893/ [4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843411/ [5] https://www.healthline.com/health/vyvanse-overdose [6] https://www.webmd.com/drugs/2/drug-15514/vyvanse-oral/details [7] https://www.drugs.com/vyvanse-patent-expiration-date.html
Other Questions About Vyvanse :